Institute for Healthcare Improvement
300 Longwood Ave, Enders 609
Div of I D
Boston
MAUSA
02115
Biographical Sketch: Dr. Goldmann >30 years experience in HAI epidemiology and QI research. He began his work at CDC where he participated in the development of NNIS (now NHSN). He served on CDC’s HICPAC and the Steering Committee of the NACHRI/CDC Pediatric Prevention Network. He was Co-PI of the Bacteriology and Mycology Study Group and chaired Risk Group 4, “Antimicrobial Resistance in Intensive Care Unit Patients.” He is a SHEA Past-President. Dr. Goldmann has used infection control as a model QI in developing countries, including Brazil, Thailand, and Indonesia (development of validated methods to assess infection control programs), Hungary and Poland (training of QI teams; national surveillance), Colombia (reduction in C-section infections), Russia (infection control training initiative), Ukraine (hospital and microbiology lab assessments), Mexico, (QI methods to prevent pediatric nosocomial infection, and the Philippines (infection prevention collaborative and a clinical trial of interventions to reduce antibiotic resistance in NICUs). Dr. Goldmann has a long track record in pediatric patient safety. He was faculty for the IHI's first “Breakthrough Series” Medical Errors and Adverse Events Collaborative. He is faculty for Vermont Oxford Network’s NIC/Q neonatal ICU QI collaborative, focusing on medical errors and HAIs. He was PI on a grant from the Harvard Risk Management Foundation, which provided the first comprehensive data on drug errors and adverse events in hospitalized children. He was a co-investigator on the Harvard Centers of Excellence for Patient Safety Research (AHRQ PO1) and Center for Patient Safety in Neonatal Care (AHRQ DCERPS). He is Co-investigator on a CDC grant to apply systems improvement to disaster preparedness. He co-directs the Harvard-wide Pediatric Health Services Research Fellowship. Dr. Goldmann is Sr VP at IHI, Professor of Pediatrics at Harvard Medical School, and Professor of Immunology and Infectious Diseases, and Epidemiology at the Harvard School of Public Health.